Cas:593-56-6 O-Methoxyamine HCl manufacturer & supplier

We serve Chemical Name:O-Methoxyamine HCl CAS:593-56-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

O-Methoxyamine HCl

Chemical Name:O-Methoxyamine HCl
CAS.NO:593-56-6
Synonyms:(aminooxy)methane hydrochloride;O-methyl-hydroxylammonium chloride;EINECS 209-798-7;methane, (aminooxy)-, hydrochloride;Methoxylamine hydrochloride;Methoxyamine hydrochloride;METHYOXYAMINE HCL;O-methyl hydroxylamine hydrochloride;(Aminooxy)methane hydrochloride (1:1);methyloxyammoniumchloride;MFCD00012951;O-Methylhydroxylamine hydrochloride;O-Methoxyamine HCl;METHOXYAMINE HCL;MAH;Methane, (aminooxy)-, hydrochloride (1:1);O-METHYLHYDROXYLAMINE HCL;Hydroxylamine, O-methyl-, hydrochloride;MOX REAGENT;Methoxyamine, hydrochloride;methoxy-amine hydrochloride;N-methoxyamine hydrochloride
Molecular Formula:CH6ClNO
Molecular Weight:83.517
HS Code:2922199090

Physical and Chemical Properties:
Melting point:151-154 °C(lit.)
Boiling point:105-110°C
Density:1.1 g/mL at 25 °C
Index of Refraction:n20/D 1.4021
PSA:35.25000
Exact Mass:83.013794
LogP:1.00880

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3265 8/PG 2
Packing Group:III


Contact us for information like (aminooxy)methane hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-methoxyamine hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00012951 Use and application,O-methyl hydroxylamine hydrochloride technical grade,usp/ep/jp grade.


Related News: The Institute for Clinical and Economic Review (ICER) on Friday released its report examining the cost-effectiveness of Soliris, also known as eculizumab, as well as up-and-comer efgartigimod for patients with the myasthenia gravis. Ethanone, 1-(1,2-dimethyl-1H-indol-3-yl)-2-phenyl-, oxime, (Z)- manufacturers As for the consumer health unit, GSK plans to demerge it by mid-2022, during which GSK will shed at least 80% of its 68% holding in the JV to shareholders. 6β-OH trimegestone suppliers The jury unanimously ruled in Plexxikon’s favor on all seven questions, including that Novartis has not proved the specification of the patent was full and clear enough to enable a person of “ordinary skill” to make and use the invention. Trispiro(3.1.1.5.1.1)pentadecan-carbonsaeure-(2) vendor & factory The Institute for Clinical and Economic Review (ICER) on Friday released its report examining the cost-effectiveness of Soliris, also known as eculizumab, as well as up-and-comer efgartigimod for patients with the myasthenia gravis. ,An inherent advantage of using enzymes for synthetic chemistry is that they increase regio-, enantio-, and stereoselectivity for more efficient conversion of substrate to product.